AbbVie, the company behind Botox, makes almost of all of the product in Westport, Co Mayo. The Trump administration had until the start of February to announce the next round of drugs selected for price cuts, which will take effect in 2028. In total, the selected drugs accounted for approximately $27bn (€22.6bn) in total prescription drug spending under Medicare Part B and Part D, representing about 6% of total spending. Novo Nordisk's best-selling weight-loss and diabetes drugs Wegovy and Ozempic headlined the 2025 list of drugs targeted for negotiations. Drugmakers have fought the price negotiations with lawsuits and claims that the lower prices deplete them of incentives to develop new drugs.

Source: Irish Examiner January 28, 2026 16:00 UTC